Watch 7:11
Why antibody tests, a crucial step toward overcoming COVID-19, are still unreliable
Testing, both for active cases of COVID-19 and for antibodies indicating prior exposure to the disease, will be critical to resuming economic activity. In addition, scientists are racing to develop therapies for people who do get infected -- especially those…
Watch 7:00
We need a vaccine to vanquish COVID-19. Here’s how scientists are trying to find it
Science correspondent Miles O’Brien has spent the past few weeks in Seattle, reporting on the COVID-19 pandemic and producing a film for FRONTLINE about how things unfolded in the city where the disease made its U.S. debut. He joins William…
How universities are developing COVID-19 solutions in real time
Dorms are empty and classroom lights are off at the vast majority of America’s colleges and universities, but that hasn’t stopped many in academia from jumping in to help.
Watch 12:23
Bill Gates on where the COVID-19 pandemic will hurt the most
Microsoft co-founder Bill Gates has spent the last few decades working to improve global health through his philanthropic organization, the Bill & Melinda Gates Foundation. One area of focus has been reducing the spread of infectious disease -- a mission…
PBS NewsHour breaks down the U.S. fall and rise of the measles in 3 charts.
A new study reminds us of how much vaccine effectiveness hinges on one thing: our personal genetics.
The law takes effect immediately but will give unvaccinated students up to 30 days after they enter a school to show they've had the first dose of each required immunization.
Cases have surged again, and are on pace to set a record for most illnesses in 25 years.
In social media's battle against misinformation, bogus claims about the dangers of vaccines are the next target.
Additional Support Provided By:
